According to filings with the U.S. Securities and Exchange Commission, Entheos Labs is raising up to $10,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Alexander Edwards played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Entheos Labs
Founded by a world-class team of scientific experts and business leaders, Entheos Labs is dedicated to discovering, developing, and deploying groundbreaking psychedelic medicines to address unmet medical needs. Entheos Labs is creating a pipeline of new chemical entities from a variety of overlooked, unscheduled psychedelic materials. We are focused on developing innovative treatments that are designed to help those who suffer from mood, anxiety, trauma-based, and substance use disorders.

To learn more about Entheos Labs, visit http://www.entheoslabs.com/
Entheos Labs Linkedin Page: https://www.linkedin.com/company/entheos-labs/

Contact:
Alexander Edwards, Chief Executive Officer
617-651-3442

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.